European Society for Medical Oncology (ESMO): Annual Flu Jab May Pose Greater Risk for Lung Cancer Patients Under Immunotherapy

Oncology April 26, 2017 at 8:40 AM 0 comments

Geneva, Switzerland, 26 April, 2017 – Lung cancer patients treated with immunotherapy may be at increased risk of adverse events after receiving the seasonal influenza vaccination, according to the first ever study measuring this effect. Results will be presented at the European Lung Cancer Conference (ELCC) 2017 in Geneva, byRead More

Polyganics Announces Enrollment of the First Patient in its PROTECT NEURO Study

Uncategorized April 20, 2017 at 10:55 AM 0 comments

Groningen, The Netherlands, April 20, 2017 – Polyganics, a privately held medical technology company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, announced today that it has enrolled the first patient in its international PROTECT NEURO study to treat and prevent symptomatic neuroma. TheRead More

RedHill Biopharma Receives Notice of Allowance for Two Additional U.S. Patents Covering BEKINDA®

Gastroenterology April 18, 2017 at 2:14 PM 0 comments

RedHill received Notices of Allowance from the United States Patent and Trademark Office (USPTO) for two new patents covering BEKINDA® (RHB-102), expected to be valid until at least 2034, once granted BEKINDA® is a proprietary, bimodal extended-release, once-daily oral pill formulation of ondansetron, targeting several gastrointestinal indications Top-line results fromRead More

LifeCodexx and Charité to Form Research Alliance Following Successful Clinical Proof-Of Principle for Molecular Genetic-Based Preeclampsia Assay

Uncategorized April 11, 2017 at 12:03 PM 0 comments

Proprietary qPCR assay planned to be ready to market during 2018 Konstanz/Berlin, Germany, April 11, 2017 – LifeCodexx AG, a leading European NIPT provider, and the Department of Obstetrics of the Charité have formed a research alliance to intensify research and development of a novel molecular genetic-based assay for the earlyRead More

The UK Should Look to Digital Platforms to Improve Services for Mental Health Sufferers

Neurology April 11, 2017 at 12:00 PM 0 comments

An online therapy service in Finland is assisting mental health individuals who feel they cannot go to see a therapist/doctor in confidence. First set up 10 years ago, this service is now available across the country. Patients who use the online service are initially assessed through a questionnaire and dependingRead More

Asceneuron Receives Regulatory Approval for Phase I Healthy Volunteer Study of Oral Tau Inhibitor

Neurology April 6, 2017 at 9:48 AM 0 comments

First-in-human trial of novel inhibitor targeting accumulation of toxic neurofibrillary tau tangles to fight neurodegenerative diseases including dementia. Lausanne, Switzerland, April 06, 2017 – Asceneuron SA, an emerging leader in the development of innovative small molecules for neurodegenerative diseases, announced today the regulatory approval of its clinical trial application to initiateRead More

RedHill Biopharma Receives FDA Orphan Drug Designation for YELIVA® for the Treatment of Cholangiocarcinoma

Oncology April 5, 2017 at 10:36 AM 0 comments

Orphan Drug designation allows RedHill to benefit from various development incentives to develop YELIVA® (ABC294640) for cholangiocarcinoma, as well as a seven-year marketing exclusivity period for the indication, if approved for marketing A Phase IIa clinical study with YELIVA® in patients with advanced, unresectable, intrahepatic and extrahepatic cholangiocarcinoma is plannedRead More

Australia’s Bionic Vision Technologies Raises US$18 Million (AU$23.5 M) to Develop ‘Bionic Eye’ for Global Markets

Australia’s Bionic Vision Technologies Raises US$18 Million (AU$23.5 M) to Develop ‘Bionic Eye’ for Global Markets

Uncategorized April 5, 2017 at 10:26 AM 0 comments

Melbourne, Australia, April 03, 2017 – Retinal implant innovator Bionic Vision Technologies (BVT) today announced it had raised US $18 million (AU$23.5 million) from Hong Kong-based China Huarong International Holdings Ltd and State Path Capital Limited, to develop and commercialise its next generation devices aimed at restoring vision to theRead More

Imanova Receives £1M Award from the MRC To Develop Early Markers of Dementia –The MIND-MAPS Study

Neurology April 5, 2017 at 10:20 AM 0 comments

London, UK, April 03, 2017 – Following a £0.5m Medical Research Council (MRC) grant to implement new Positron Emission Tomography (PET) imaging tracers for mitochondrial dysfunction and synaptic loss, Imanova has been awarded an additional £1m of strategic funding from the MRC for clinical evaluation of this combination of tracersRead More

ELCC 2017: Latest News in Lung Cancer

Oncology, Respiratory April 5, 2017 at 10:15 AM 0 comments

Geneva, Switzerland, May 5-8 2017 – Around 2,000 delegates from across Europe and worldwide will learn about the latest practice-changing science in the field of thoracic oncology at the seventh European Lung Cancer Conference (ELCC) in Geneva, Switzerland, from 5 to 8 May 2017. Key themes at this year’s meeting includeRead More